P3 Study in Acne Comparing Once Daily SB204 and Vehicle
Status:
Completed
Trial end date:
2016-12-21
Target enrollment:
Participant gender:
Summary
This is a 12 week, multi-center, double-blinded, randomized, vehicle-controlled, parallel
group, study to be conducted in approximately 1300 subjects with acne vulgaris in the US.